These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8419197)

  • 1. Ovarian sensitivity to follicle-stimulating hormone during the follicular phase of the human menstrual cycle and in patients with polycystic ovarian syndrome.
    Caruso A; Fortini A; Fulghesu AM; Pistilli E; Cucinelli F; Lanzone A; Mancuso S
    Fertil Steril; 1993 Jan; 59(1):115-20. PubMed ID: 8419197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone enhances estradiol production follicle-stimulating hormone-induced in the early stage of the follicular maturation.
    Lanzone A; Fortini A; Fulghesu AM; Soranna L; Caruso A; Mancuso S
    Fertil Steril; 1996 Dec; 66(6):948-53. PubMed ID: 8941060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone administration normalizes the ovarian responsiveness to follicle-stimulating-hormone in the early stages of the follicular maturation in women with Down syndrome.
    Cento RM; Ragusa L; Proto C; Alberti A; Fiore G; Soranna L; Colabucci F; Lanzone A
    J Endocrinol Invest; 1998 Jun; 21(6):342-7. PubMed ID: 9699124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I; Hop WC; Fauser BC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extremely high levels of estradiol and testosterone in a case of polycystic ovarian syndrome. Hormone and clinical similarities with the phenotype of the alpha estrogen receptor null mice.
    Bartolone L; Smedile G; Arcoraci V; Trimarchi F; Benvenga S
    J Endocrinol Invest; 2000; 23(7):467-72. PubMed ID: 11005272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries.
    Elting MW; Kwee J; Schats R; Rekers-Mombarg LT; Schoemaker J
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1589-95. PubMed ID: 11297588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women.
    Rosencrantz MA; Wachs DS; Coffler MS; Malcom PJ; Donohue M; Chang RJ
    Hum Reprod; 2010 Jan; 25(1):198-203. PubMed ID: 19850592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of bioactive follicle-stimulating hormone secretion in women with polycystic ovary syndrome: effects of estradiol and progesterone.
    Padmanabhan V; Christman GM; Randolph JF; Kelch RP; Marshall JC; Beitins IZ
    Fertil Steril; 2001 May; 75(5):881-8. PubMed ID: 11334898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obligatory roles for follicle-stimulating hormone (FSH), estradiol and androgens in the induction of small polyfollicular ovarian cysts in hypophysectomized immature rats.
    Bogovich K
    Endocrine; 2007 Apr; 31(2):179-92. PubMed ID: 17873331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian sensitivity to follicle stimulating hormone is blunted in normo-ovulatory women with Down's syndrome.
    Cento RM; Ragusa L; Proto C; Alberti A; Fiore G; Colabucci F; Lanzone A
    Hum Reprod; 1997 Aug; 12(8):1709-13. PubMed ID: 9308798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S; van der Spuy ZM
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters.
    Jin J; Ruan X; Hua L; Tian X; Li Y; Wang L; Mueck AO
    Gynecol Endocrinol; 2017 Sep; 33(9):694-697. PubMed ID: 28412857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone.
    Lee MS; Lanes A; Dolinko AV; Bailin A; Ginsburg E
    J Assist Reprod Genet; 2020 Sep; 37(9):2293-2304. PubMed ID: 32623663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GnRH analog administration in patients with polycystic ovarian disease.
    Meden-Vrtovec H
    Int J Gynaecol Obstet; 1995 Aug; 50(2):179-83. PubMed ID: 7589755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.
    Sullivan MW; Stewart-Akers A; Krasnow JS; Berga SL; Zeleznik AJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):228-32. PubMed ID: 9920089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.